StockpollyBeta
Get App
Delisting riskPopularity #4,280
ARTL · NASDAQ · Biotechnology

Artelo Biosciences (ARTL)

Develops cannabinoid and fatty-acid-binding-protein drug candidates for cancer supportive care and pain.

$4.23
After hours+0.06 (+1.41%)
At close$4.18(+1.83%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
333314233333
Research & development222202121111
111111112222
General & administrative111111112222
Operating income−3−3−3−3−1−4−2−3−3−3−3−3
000000000−100
Interest income000000000000
Interest expense000000000000
Other non-operating income000000000100
Income before tax−2−3−2−2−1−4−2−3−3−4−3−2
Net income from continuing operations−2−3−2−2−1−4−2−3−3−4−3−2
Net income−2−3−2−2−1−4−2−3−3−4−3−2
EPS, basic−$0.28−$17.34−$2.34−$2.25−$1.05−$21.00−$2.16−$16.83−$11.91−$18.36−$36.00−$8.01
EPS, diluted−$0.28−$17.34−$2.34−$2.25−$1.05−$21.00−$2.16−$16.83−$11.91−$18.36−$36.00−$8.01
Weighted average shares, basic101110100000
Weighted average shares, diluted101110100000
EBITDA−3−3−2−2−1−4−2−3−3−4−3−2
Depreciation & amortization000000000000
EBIT−3−3−2−2−1−4−2−3−3−4−3−2